Dr. Pasi Jänne led a study that showed a drug shrank lung tumors in 61 percent of patients whose cancers had developed the T790-M resistance mutation. He also commented on personalized medicine for cancer patients.
Tags: LungCancer, TargetedTherapy
Tags: Genomics, TargetedTherapy
Dr. Edward J. Benz, Jr., talked about research to develop treatments for cancer that are more efficient and less toxic, by specifically targeting tumors using genetic analysis.
Tags: BasicResearch, TargetedTherapy
Tags: BasicResearch, TargetedTherapy, Genetics
Tags: MultipleMyeloma, TargetedTherapy
Tags: TargetedTherapy, BrainTumors
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: